GE HealthCare Technologies (GE HealthCare Technologies) Change In Receivables : $34 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GE HealthCare Technologies Change In Receivables?

GE HealthCare Technologies's change in receivables for the quarter that ended in Mar. 2024 was $200 Mil. It means GE HealthCare Technologies's Accounts Receivable declined by $200 Mil from Dec. 2023 to Mar. 2024 .

GE HealthCare Technologies's change in receivables for the fiscal year that ended in Dec. 2023 was $-171 Mil. It means GE HealthCare Technologies's Accounts Receivable increased by $171 Mil from Dec. 2022 to Dec. 2023 .

GE HealthCare Technologies's Accounts Receivable for the quarter that ended in Mar. 2024 was $3,148 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. GE HealthCare Technologies's Days Sales Outstanding for the three months ended in Mar. 2024 was 61.78.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. GE HealthCare Technologies's liquidation value for the three months ended in Mar. 2024 was $-18,703 Mil.

GE HealthCare Technologies Change In Receivables Historical Data

The historical data trend for GE HealthCare Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Change In Receivables Chart

GE HealthCare Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-291.00

-257.00

-1,156.00

-440.00

-171.00

GE HealthCare Technologies Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial								-5.00	-81.00	-62.00	-23.00	200.00

GE HealthCare Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $34 Mil.

GE HealthCare Technologies (NAS:GEHC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

GE HealthCare Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3148	/	4650	*	91
=	61.78

2. In Ben Graham's calculation of liquidation value, GE HealthCare Technologies's accounts receivable are only considered to be worth 75% of book value:

GE HealthCare Technologies's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2551	-	24609	+	0.75 * 3148	+	0.5 * 1989
=	-18,703

GE HealthCare Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

GE HealthCare Technologies (GE HealthCare Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

GEHC:Mexico L0T:Germany

Address

500 West Monroe Street, Chicago, IL, USA, 60661

Website

https://www.gehealthcare.com

GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.

Executives

Kevin Michael O'neill	officer: CEO, PDx	500 W. MONROE STREET, CHICAGO IL 60661
Roland Rott	officer: CEO, Ultrasound	500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro	officer: Chief Financial Officer	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jan Makela	officer: CEO, Imaging	500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout	officer: Chief Technology Officer	500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski	officer: Ch. Supply Chain & Serv. Ofc.	500 W MONROE, CHICAGO IL 60661
Culp H Lawrence Jr	director	GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg	director	100 E. PRATT STREET, BALTIMORE MD 21202
Thomas J. Westrick	officer: CEO, Patient Care Solutions	500 W. MONROE STREET, CHICAGO IL 60661
Yang Watkin Phoebe L.	director	C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman	director	21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic	director	ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell	director	8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden	director	C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202
Frank R Jimenez	officer: GC & Corporate Secretary	GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061